The loss of FGFR4 has been shown to affect metabolism; Huang et al. showed that Fgfr4−/− mice developed features of the metabolic syndrome, including an increase in white adipose tissue mass, insulin resistance, glucose intolerance, and hyperlipidemia, when challenged with a high-fat diet (15). Here, FGFR4 is linked to hyperlipidemia.